Antagonists of the EP3 receptor for prostaglandin E2 are novel antiplatelet agents that do not prolong bleeding.
Singh J, Zeller W, Zhou N, Hategen G, Mishra R, Polozov A, Yu P, Onua E, Zhang J, Zembower D, Kiselyov A, Ramírez JL, Sigthorsson G, Bjornsson JM, Thorsteinsdottir M, Andrésson T, Bjarnadottir M, Magnusson O, Fabre JE, Stefansson K, Gurney ME.
Singh J, et al. Among authors: polozov a.
ACS Chem Biol. 2009 Feb 20;4(2):115-26. doi: 10.1021/cb8002094.
ACS Chem Biol. 2009.
PMID: 19193156